Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 29127379)

  • 1. RSPO3 antagonism inhibits growth and tumorigenicity in colorectal tumors harboring common Wnt pathway mutations.
    Fischer MM; Yeung VP; Cattaruzza F; Hussein R; Yen WC; Murriel C; Evans JW; O'Young G; Brunner AL; Wang M; Cain J; Cancilla B; Kapoun A; Hoey T
    Sci Rep; 2017 Nov; 7(1):15270. PubMed ID: 29127379
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RSPO3 expands intestinal stem cell and niche compartments and drives tumorigenesis.
    Hilkens J; Timmer NC; Boer M; Ikink GJ; Schewe M; Sacchetti A; Koppens MAJ; Song JY; Bakker ERM
    Gut; 2017 Jun; 66(6):1095-1105. PubMed ID: 27511199
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic Targeting of Tumor-Derived R-Spondin Attenuates β-Catenin Signaling and Tumorigenesis in Multiple Cancer Types.
    Chartier C; Raval J; Axelrod F; Bond C; Cain J; Dee-Hoskins C; Ma S; Fischer MM; Shah J; Wei J; Ji M; Lam A; Stroud M; Yen WC; Yeung P; Cancilla B; O'Young G; Wang M; Kapoun AM; Lewicki J; Hoey T; Gurney A
    Cancer Res; 2016 Feb; 76(3):713-23. PubMed ID: 26719531
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comprehensive characterization of RSPO fusions in colorectal traditional serrated adenomas.
    Sekine S; Ogawa R; Hashimoto T; Motohiro K; Yoshida H; Taniguchi H; Saito Y; Yasuhiro O; Ochiai A; Hiraoka N
    Histopathology; 2017 Oct; 71(4):601-609. PubMed ID: 28543708
    [TBL] [Abstract][Full Text] [Related]  

  • 5. R-spondin-3 is an oncogenic driver of poorly differentiated invasive breast cancer.
    Ter Steege EJ; Boer M; Timmer NC; Ammerlaan CM; Song JY; Derksen PW; Hilkens J; Bakker ER
    J Pathol; 2022 Nov; 258(3):289-299. PubMed ID: 36106661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of RNF43 frameshift mutations that drive Wnt ligand- and R-spondin-dependent colon cancer.
    Yamamoto D; Oshima H; Wang D; Takeda H; Kita K; Lei X; Nakayama M; Murakami K; Ohama T; Takemura H; Toyota M; Suzuki H; Inaki N; Oshima M
    J Pathol; 2022 May; 257(1):39-52. PubMed ID: 35040131
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinicopathological and molecular characteristics of RSPO fusion-positive colorectal cancer.
    Hashimoto T; Takayanagi D; Yonemaru J; Naka T; Nagashima K; Yatabe Y; Shida D; Hamamoto R; Kleeman SO; Leedham SJ; Maughan T; Takashima A; Shiraishi K; Sekine S
    Br J Cancer; 2022 Oct; 127(6):1043-1050. PubMed ID: 35715628
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel tankyrase small-molecule inhibitor suppresses APC mutation-driven colorectal tumor growth.
    Lau T; Chan E; Callow M; Waaler J; Boggs J; Blake RA; Magnuson S; Sambrone A; Schutten M; Firestein R; Machon O; Korinek V; Choo E; Diaz D; Merchant M; Polakis P; Holsworth DD; Krauss S; Costa M
    Cancer Res; 2013 May; 73(10):3132-44. PubMed ID: 23539443
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TRIB3 Interacts With β-Catenin and TCF4 to Increase Stem Cell Features of Colorectal Cancer Stem Cells and Tumorigenesis.
    Hua F; Shang S; Yang YW; Zhang HZ; Xu TL; Yu JJ; Zhou DD; Cui B; Li K; Lv XX; Zhang XW; Liu SS; Yu JM; Wang F; Zhang C; Huang B; Hu ZW
    Gastroenterology; 2019 Feb; 156(3):708-721.e15. PubMed ID: 30365932
    [TBL] [Abstract][Full Text] [Related]  

  • 10. WNT antagonists exhibit unique combinatorial antitumor activity with taxanes by potentiating mitotic cell death.
    Fischer MM; Cancilla B; Yeung VP; Cattaruzza F; Chartier C; Murriel CL; Cain J; Tam R; Cheng CY; Evans JW; O'Young G; Song X; Lewicki J; Kapoun AM; Gurney A; Yen WC; Hoey T
    Sci Adv; 2017 Jun; 3(6):e1700090. PubMed ID: 28691093
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular genetics and targeted therapy of WNT-related human diseases (Review).
    Katoh M; Katoh M
    Int J Mol Med; 2017 Sep; 40(3):587-606. PubMed ID: 28731148
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel Bispecific Domain Antibody to LRP6 Inhibits Wnt and R-spondin Ligand-Induced Wnt Signaling and Tumor Growth.
    Jackson H; Granger D; Jones G; Anderson L; Friel S; Rycroft D; Fieles W; Tunstead J; Steward M; Wattam T; Walker A; Griggs J; Al-Hajj M; Shelton C
    Mol Cancer Res; 2016 Sep; 14(9):859-68. PubMed ID: 27401612
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RSPO fusion transcripts in colorectal cancer in Japanese population.
    Shinmura K; Kahyo T; Kato H; Igarashi H; Matsuura S; Nakamura S; Kurachi K; Nakamura T; Ogawa H; Funai K; Tanahashi M; Niwa H; Sugimura H
    Mol Biol Rep; 2014 Aug; 41(8):5375-84. PubMed ID: 24847761
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of AXIN1 drives acquired resistance to WNT pathway blockade in colorectal cancer cells carrying RSPO3 fusions.
    Picco G; Petti C; Centonze A; Torchiaro E; Crisafulli G; Novara L; Acquaviva A; Bardelli A; Medico E
    EMBO Mol Med; 2017 Mar; 9(3):293-303. PubMed ID: 28100566
    [TBL] [Abstract][Full Text] [Related]  

  • 15. R-Spondins 2 and 3 Are Overexpressed in a Subset of Human Colon and Breast Cancers.
    Conboy CB; Vélez-Reyes GL; Rathe SK; Abrahante JE; Temiz NA; Burns MB; Harris RS; Starr TK; Largaespada DA
    DNA Cell Biol; 2021 Jan; 40(1):70-79. PubMed ID: 33320737
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    Niu J; Guan J; Li R; Li X; Zhai J; Qi J; He Y
    Int J Mol Sci; 2018 Jun; 19(7):. PubMed ID: 29966290
    [No Abstract]   [Full Text] [Related]  

  • 17. RSPO3 promotes the aggressiveness of bladder cancer via Wnt/β-catenin and Hedgehog signaling pathways.
    Chen Z; Zhou L; Chen L; Xiong M; Kazobinka G; Pang Z; Hou T
    Carcinogenesis; 2019 Apr; 40(2):360-369. PubMed ID: 30329043
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of R-spondin proteins in cancer biology.
    Ter Steege EJ; Bakker ERM
    Oncogene; 2021 Nov; 40(47):6469-6478. PubMed ID: 34663878
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Scutellaria barbata D. Don inhibits colorectal cancer growth via suppression of Wnt/β-catenin signaling pathway.
    Wei LH; Lin JM; Chu JF; Chen HW; Li QY; Peng J
    Chin J Integr Med; 2017 Nov; 23(11):858-863. PubMed ID: 29080197
    [TBL] [Abstract][Full Text] [Related]  

  • 20. R-spondins can potentiate WNT signaling without LGRs.
    Lebensohn AM; Rohatgi R
    Elife; 2018 Feb; 7():. PubMed ID: 29405118
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.